Wells Fargo & Company Dyadic International Inc Transaction History
Wells Fargo & Company
- $507 Billion
- Q3 2025
A detailed history of Wells Fargo & Company transactions in Dyadic International Inc stock. As of the latest transaction made, Wells Fargo & Company holds 178 shares of DYAI stock, worth $163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178
Previous 178
-0.0%
Holding current value
$163
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding DYAI
# of Institutions
42Shares Held
6.21MCall Options Held
0Put Options Held
0-
Apis Capital Advisors, LLC New York, NY1.54MShares$1.42 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA915KShares$841,7630.0% of portfolio
-
Chapin Davis, Inc. Baltimore, MD888KShares$816,9630.2% of portfolio
-
Perkins Capital Management Inc348KShares$320,2060.41% of portfolio
-
Truist Financial Corp326KShares$300,1040.0% of portfolio
About DYADIC INTERNATIONAL INC
- Ticker DYAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,423,100
- Market Cap $26.1M
- Description
- Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...